BVF Inc’s Mereo BioPharma MREO Stock Holding History

BVF Inc’s Portfolio MREO Stock Details MREO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-523,382	Closed	-$1.52M	–	59
2019 Q3	$1.52M	Hold	523,382	–	–	0.16%	53
2019 Q2	$1.26M	Buy	+523,382	New	+$2.29M	0.14%	54

Other funds holding MREO

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

DMPV

Delphi Management Partners VIII San Mateo, California $138M AUM 56.74% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

BVF Inc's MREO Position: Q4 2019 in Review

BVF Inc sold out of Mereo BioPharma (MREO) in Q4 2019, closing a stake of 523,382 shares — an estimated $1.52M sold.

BVF Inc first reported a position in MREO in Q2 2019 and held it in 2 quarters. The position peaked at $1.52M in Q3 2019. 14 funds tracked by Wall St. Rank hold MREO as of Q4 2019.

BVF Inc reported no remaining Mereo BioPharma position as of Q4 2019 after selling out during the quarter.
BVF Inc sold 523,382 Mereo BioPharma shares in Q4 2019, an estimated $1.52M.
BVF Inc first reported a position in Mereo BioPharma in Q2 2019 and held it in 2 quarters.
BVF Inc's Mereo BioPharma position peaked at $1.52M in Q3 2019.
14 funds tracked by Wall St. Rank held Mereo BioPharma as of Q4 2019.

Based on BVF Inc's 13F filing for Q4 2019, filed 14 Feb 2020.